Tag Archives: transparency

"Sunshine" Just the Tip of the Iceberg: Pharma and Full Disclosure

By Jill Wechsler | Published: April 10, 2013
“Sunshine” Just the Tip of the Iceberg: Full Disclosure for Pharma:??There seems no end to demands for data on clinical research, conflicts of interest, company payments, and drug prices, writes Jill Wechsler. Although recent legislation and regulations have greatly expanded the range of information that pharmaceutical companies have to unveil to the public, there’s an escalating [...]
Posted in Guest Blog, Op-Ed, Regulatory, Safety, Strategy, healthcare, pricing | Also tagged , , , | 1 Comment

The Year to Come: EMA's Plans Announced

By Clark Herman | Published: December 20, 2012
At the end of last month, the European Medicines Agency approved its budget and work program for the coming year, promising to implement measures to increase operational efficiency, enhance transparency and communication with stakeholders, and improve the quality and consistency of rulemaking. With a 4.1% increase in budget to €231.6 million and an anticipated 54 [...]
Posted in Europe, Regulatory, Safety, Strategy | Also tagged , , | Leave a comment

Compliance: Europe Feels the Sunshine

By Julian Upton | Published: February 15, 2012
As the perceived urgency for transparency and compliance in global pharma grows ever stronger, the ‘Sunshine provisions’ of the US’s Patient Protection and Affordable Care Act (ACA) seem increasingly aptly named. The spotlight that has been exposing and illuminating – and sometimes burning – issues around the financial interests of physicians and academic medical centers [...]
Posted in Europe, compliance | Also tagged , , , , , | Leave a comment

Gift Giving Must Stop Says ProPublica

By Jennifer Ringler | Published: May 9, 2011
According to ProPublica—though transparency has seemingly increased between pharma and physicians since the Christmastime release of its Dollars for Docs report—medical societies and organizations are still having a holiday with industry money. Three days before Christmas last year, independent news organization ProPublica released its own “naughty and nice” list in the form of its Dollars for [...]
Posted in Meetings, Regulatory | Also tagged , , | 1 Comment

Regulator Move Re-Opens Arguments over European Transparency

By Julian Upton | Published: March 9, 2011
At the end of last month, European public health and transparency campaigners sent a letter to EC health commissioner John Dalli, outlining their concerns about former EMA head Thomas Lönngren’s recent career move. The Alliance for Lobbying Transparency and Ethics Regulation (ALTER-EU), Health Action International (HAI) Europe, the International Society of Drug Bulletins (ISDB) — and [...]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment